Global Refined Guanxin Tablets 麻豆原创 Research Report 2024

Publication ID:

PB512246505

Publication Date:

December 4, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Refined Guanxin Tablets was valued at US$ 42.7 million in the year 2023 and is projected to reach a revised size of US$ 60.9 million by 2030, growing at a CAGR of 5.7% during the forecast period.
Refined Guanxin Tablets are a Chinese patent medicine, mainly composed of Danshen, Chuanxiong, Red Peony Root, Curcuma, Panax Notoginseng, Choerospondias, Safflower, Borneol, etc. It has the effects of promoting blood circulation and removing blood stasis, regulating qi and relieving pain. It is specially used to treat coronary heart disease, angina pectoris, myocardial infarction, heart failure, arrhythmia, palpitation and shortness of breath, and atrial fibrillation caused by various reasons.
North American market for Refined Guanxin Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Refined Guanxin Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Refined Guanxin Tablets include Guangdong Yishu Pharmaceutical Co., Ltd., Guangdong Heping Pharmaceutical Co., Ltd., Guangxi Jinhaitang Pharmaceutical Co., Ltd., Sanjin Group Hunan Sanjin Pharmaceutical Co., Ltd., Guangxi Weiwei Pharmaceutical Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Refined Guanxin Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Refined Guanxin Tablets.
The Refined Guanxin Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Refined Guanxin Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Refined Guanxin Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Guangdong Yishu Pharmaceutical Co., Ltd.
Guangdong Heping Pharmaceutical Co., Ltd.
Guangxi Jinhaitang Pharmaceutical Co., Ltd.
Sanjin Group Hunan Sanjin Pharmaceutical Co., Ltd.
Guangxi Weiwei Pharmaceutical Co., Ltd.
Segment by Type
Film-coated Tablets
Sugar-coated Tablets
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Refined Guanxin Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Refined Guanxin Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Refined Guanxin Tablets 麻豆原创 Overview
1.1 Product Definition
1.2 Refined Guanxin Tablets by Type
1.2.1 Global Refined Guanxin Tablets 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Film-coated Tablets
1.2.3 Sugar-coated Tablets
1.3 Refined Guanxin Tablets by Application
1.3.1 Global Refined Guanxin Tablets 麻豆原创 Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Refined Guanxin Tablets 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Refined Guanxin Tablets Revenue 2019-2030
1.4.2 Global Refined Guanxin Tablets Sales 2019-2030
1.4.3 Global Refined Guanxin Tablets 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Refined Guanxin Tablets 麻豆原创 Competition by Manufacturers
2.1 Global Refined Guanxin Tablets Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Refined Guanxin Tablets Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Refined Guanxin Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Refined Guanxin Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Refined Guanxin Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Refined Guanxin Tablets, Product Type & Application
2.7 Global Key Manufacturers of Refined Guanxin Tablets, Date of Enter into This Industry
2.8 Global Refined Guanxin Tablets 麻豆原创 Competitive Situation and Trends
2.8.1 Global Refined Guanxin Tablets 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Refined Guanxin Tablets Players 麻豆原创 Share by Revenue
2.8.3 Global Refined Guanxin Tablets 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Refined Guanxin Tablets 麻豆原创 Scenario by Region
3.1 Global Refined Guanxin Tablets 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Refined Guanxin Tablets Sales by Region: 2019-2030
3.2.1 Global Refined Guanxin Tablets Sales by Region: 2019-2024
3.2.2 Global Refined Guanxin Tablets Sales by Region: 2025-2030
3.3 Global Refined Guanxin Tablets Revenue by Region: 2019-2030
3.3.1 Global Refined Guanxin Tablets Revenue by Region: 2019-2024
3.3.2 Global Refined Guanxin Tablets Revenue by Region: 2025-2030
3.4 North America Refined Guanxin Tablets 麻豆原创 Facts & Figures by Country
3.4.1 North America Refined Guanxin Tablets 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Refined Guanxin Tablets Sales by Country (2019-2030)
3.4.3 North America Refined Guanxin Tablets Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Refined Guanxin Tablets 麻豆原创 Facts & Figures by Country
3.5.1 Europe Refined Guanxin Tablets 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Refined Guanxin Tablets Sales by Country (2019-2030)
3.5.3 Europe Refined Guanxin Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Refined Guanxin Tablets 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Refined Guanxin Tablets 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Refined Guanxin Tablets Sales by Region (2019-2030)
3.6.3 Asia Pacific Refined Guanxin Tablets Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Refined Guanxin Tablets 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Refined Guanxin Tablets 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Refined Guanxin Tablets Sales by Country (2019-2030)
3.7.3 Latin America Refined Guanxin Tablets Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Refined Guanxin Tablets 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Refined Guanxin Tablets 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Refined Guanxin Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Refined Guanxin Tablets Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Refined Guanxin Tablets Sales by Type (2019-2030)
4.1.1 Global Refined Guanxin Tablets Sales by Type (2019-2024)
4.1.2 Global Refined Guanxin Tablets Sales by Type (2025-2030)
4.1.3 Global Refined Guanxin Tablets Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Refined Guanxin Tablets Revenue by Type (2019-2030)
4.2.1 Global Refined Guanxin Tablets Revenue by Type (2019-2024)
4.2.2 Global Refined Guanxin Tablets Revenue by Type (2025-2030)
4.2.3 Global Refined Guanxin Tablets Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Refined Guanxin Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Refined Guanxin Tablets Sales by Application (2019-2030)
5.1.1 Global Refined Guanxin Tablets Sales by Application (2019-2024)
5.1.2 Global Refined Guanxin Tablets Sales by Application (2025-2030)
5.1.3 Global Refined Guanxin Tablets Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Refined Guanxin Tablets Revenue by Application (2019-2030)
5.2.1 Global Refined Guanxin Tablets Revenue by Application (2019-2024)
5.2.2 Global Refined Guanxin Tablets Revenue by Application (2025-2030)
5.2.3 Global Refined Guanxin Tablets Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Refined Guanxin Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Guangdong Yishu Pharmaceutical Co., Ltd.
6.1.1 Guangdong Yishu Pharmaceutical Co., Ltd. Company Information
6.1.2 Guangdong Yishu Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 Guangdong Yishu Pharmaceutical Co., Ltd. Refined Guanxin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Guangdong Yishu Pharmaceutical Co., Ltd. Refined Guanxin Tablets Product Portfolio
6.1.5 Guangdong Yishu Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 Guangdong Heping Pharmaceutical Co., Ltd.
6.2.1 Guangdong Heping Pharmaceutical Co., Ltd. Company Information
6.2.2 Guangdong Heping Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Guangdong Heping Pharmaceutical Co., Ltd. Refined Guanxin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Guangdong Heping Pharmaceutical Co., Ltd. Refined Guanxin Tablets Product Portfolio
6.2.5 Guangdong Heping Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Guangxi Jinhaitang Pharmaceutical Co., Ltd.
6.3.1 Guangxi Jinhaitang Pharmaceutical Co., Ltd. Company Information
6.3.2 Guangxi Jinhaitang Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Guangxi Jinhaitang Pharmaceutical Co., Ltd. Refined Guanxin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Guangxi Jinhaitang Pharmaceutical Co., Ltd. Refined Guanxin Tablets Product Portfolio
6.3.5 Guangxi Jinhaitang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Sanjin Group Hunan Sanjin Pharmaceutical Co., Ltd.
6.4.1 Sanjin Group Hunan Sanjin Pharmaceutical Co., Ltd. Company Information
6.4.2 Sanjin Group Hunan Sanjin Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Sanjin Group Hunan Sanjin Pharmaceutical Co., Ltd. Refined Guanxin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanjin Group Hunan Sanjin Pharmaceutical Co., Ltd. Refined Guanxin Tablets Product Portfolio
6.4.5 Sanjin Group Hunan Sanjin Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Guangxi Weiwei Pharmaceutical Co., Ltd.
6.5.1 Guangxi Weiwei Pharmaceutical Co., Ltd. Company Information
6.5.2 Guangxi Weiwei Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Guangxi Weiwei Pharmaceutical Co., Ltd. Refined Guanxin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Guangxi Weiwei Pharmaceutical Co., Ltd. Refined Guanxin Tablets Product Portfolio
6.5.5 Guangxi Weiwei Pharmaceutical Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Refined Guanxin Tablets Industry Chain Analysis
7.2 Refined Guanxin Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Refined Guanxin Tablets Production Mode & Process
7.4 Refined Guanxin Tablets Sales and 麻豆原创ing
7.4.1 Refined Guanxin Tablets Sales Channels
7.4.2 Refined Guanxin Tablets Distributors
7.5 Refined Guanxin Tablets Customers
8 Refined Guanxin Tablets 麻豆原创 Dynamics
8.1 Refined Guanxin Tablets Industry Trends
8.2 Refined Guanxin Tablets 麻豆原创 Drivers
8.3 Refined Guanxin Tablets 麻豆原创 Challenges
8.4 Refined Guanxin Tablets 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Guangdong Yishu Pharmaceutical Co., Ltd.
Guangdong Heping Pharmaceutical Co., Ltd.
Guangxi Jinhaitang Pharmaceutical Co., Ltd.
Sanjin Group Hunan Sanjin Pharmaceutical Co., Ltd.
Guangxi Weiwei Pharmaceutical Co., Ltd.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.